American Heart Journal

1

Thrombin: Science and application in clinical practice

Richard C. Becker

Journal:

Year:

2005

Language:

english

File:

PDF, 35 KB

english, 2005

2

Understanding the dynamics of thrombin in cardiovascular disease: Pathobiology and biochemistry for the clinician

Richard C. Becker

Journal:

American Heart Journal

Year:

2005

Language:

english

File:

PDF, 349 KB

english, 2005

3

Thromboepidemiology: Identifying patients with heritable risk for thrombin-mediated thromboembolic events

Maichi Tran, Frederick A. Spencer

Journal:

American Heart Journal

Year:

2005

Language:

english

File:

PDF, 228 KB

english, 2005

4

Thrombin/inflammation paradigms: A closer look at arterial and venous thrombosis

Juan F. Viles-Gonzalez, Valentin Fuster, Juan J. Badimon

Journal:

American Heart Journal

Year:

2005

Language:

english

File:

PDF, 412 KB

english, 2005

5

Direct thrombin inhibitors: Stroke prevention in atrial fibrillation and potential anti-inflammatory properties

Priya Palagummi, Heath Saltzman, Michael Ezekowitz

Journal:

American Heart Journal

Year:

2005

Language:

english

File:

PDF, 73 KB

english, 2005

6

The challenge of regulating anticoagulant drugs: Focus on warfarin

Kenneth G. Mann

Journal:

American Heart Journal

Year:

2005

Language:

english

File:

PDF, 495 KB

english, 2005

7

Thrombin, an ideal target for pharmacological inhibition: A review of direct thrombin inhibitors

Hitinder S. Gurm, Deepak L. Bhatt

Journal:

American Heart Journal

Year:

2005

Language:

english

File:

PDF, 546 KB

english, 2005

8

Thrombin-directed inhibitors: Pharmacology and clinical use

C. Michael White

Journal:

American Heart Journal

Year:

2005

Language:

english

File:

PDF, 311 KB

english, 2005

9

Novel constructs for thrombin inhibition

Richard C. Becker

Journal:

American Heart Journal

Year:

2005

Language:

english

File:

PDF, 496 KB

english, 2005

10

Volume 149; Issue 1-supp-S

Thrombin: Science and application in clinical practice

Understanding the dynamics of thrombin in cardiovascular disease: Pathobiology and biochemistry for the clinician

Thromboepidemiology: Identifying patients with heritable risk for thrombin-mediated thromboembolic events

Thrombin/inflammation paradigms: A closer look at arterial and venous thrombosis

Direct thrombin inhibitors: Stroke prevention in atrial fibrillation and potential anti-inflammatory properties

The challenge of regulating anticoagulant drugs: Focus on warfarin

Thrombin, an ideal target for pharmacological inhibition: A review of direct thrombin inhibitors

Thrombin-directed inhibitors: Pharmacology and clinical use

Novel constructs for thrombin inhibition

TOC